Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Surgery for benign insulinoma: An international review

Abstract

In a multiinstitutional review, data on 396 patients with benign solitary or multiple insulinomas operated on in 15 centers were collected. In these 396 patients, 419 laparotomies (375 primary procedures and 44 reoperations) were performed. The rate of unnecessary laparotomies was 1.7%. Complications occurred after 132 operations (31.5%), requiring 27 reinterventions (6.4%). Ten (2%) patients died within 30 days of surgery. The success rate of first procedures in the centers was 94.9%. After reoperation, all but 2 (99.5%) of these patients were cured. The overall cure rate including those patients who had their primary operations elsewhere was 97.5%.

Résumé

Compilant les dossiers de 15 établissements internationaux, nous avons colligé les données concernant 396 patients présentant un insulinome bénin unique ou multiple, opérés. Chez ces 396 patients, 419 laparotomies (375 interventions de première intention et 44 reprises) ont été effectuées. Le taux de laparotomie inutile était de 1.7%. Des complications sont intervenues à la suite de 132 opérations (31.5%), nécessitant 27 réinterventions (6.4%). Dix (2%) patients sont morts dans les trente jours après l'acte chirurgical. Le taux de succès des interventions de première intention dans les centres de l'étude était de 94.9%. Après réinterventions, tous les patients sauf 2 (99.5%) ont été guéris. Le taux global de guérison, y compris les patients ayant été opérés une première fois ailleurs, était de 97.5%.

Resumen

En una revisión multiinstitucional se recolectaron los datos sobre 396 pacientes con insulinomas benignos solitarios o múltiples operados en 15 centros. En estos 396 pacientes se efectuaron 419 laparotomías (375 procedimientos primarios y 44 reoperaciones). Se registró una tasa de laparotomías innecesarias de 1.7%; se presentaron complicaciones después de 132 operaciones (31.5%), las cuales requirieron 27 reintervenciones (6.4%). Diez (2%) pacientes murieron dentro de los primeras 30 días después de la cirugía. La tasa de éxito del procedimiento primario realizado en estos centros fue 94.9%. Después de las reoperaciones la totalidad de los pacientes, menos 2 (99.5%), fueron curados. La tasa global de curación, incluyendo los que tuvieron su operación primaria por fuera de los centros del estudio, fue 97.5%.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Harrison, T.S., Child, C.G., Fry, W.J., Floyd, J.C., Fajans, S.S.: Current surgical management of functioning islet cell tumors of the pancreas. Ann. Surg.178:485, 1973

  2. 2.

    van Heerden, J.A., Edis, A.J., Service, F.J.: The surgical aspects of insulinomas. Ann. Surg.189:677, 1979

  3. 3.

    Le Quesne, L.P., Nabarro, J.D.N., Kurtz, A., Zweig, S.: The management of insulin tumors of the pancreas. Br. J. Surg.66:373, 1979

  4. 4.

    Broughan, T.A., Leslie, J.D., Soto, J.M., Hermann, R.E.: Pancreatic islet cell tumors. Surgery99:671, 1986

  5. 5.

    Galbut, D.L., Markowitz, A.M.: Insulinoma: Diagnosis, surgical management and long-term follow-up. Am. J. Surg.139:682, 1980

  6. 6.

    Peiper, H.J.: Pankreatische Apudome. Chirurg51:380, 1988

  7. 7.

    Howard, J.M., Moss, H., Rhoads, J.E.: Collective review: Hyperinsulinism and islet cell tumours of the pancreas. With 398 recorded tumours. Surg. Gynecol. Obstet.90:417, 1950

  8. 8.

    Moss, N.H., Rhoads, J.E.: Islet Cell Tumors. Surgical Diseases of the Pancreas, Philadelphia, Lippincott, 1960

  9. 9.

    Filipi, C.J., Higgins, G.A.: Diagnosis and management of insulinoma. Am. J. Surg.125:231, 1973

  10. 10.

    Stefanini, P., Carboni, M., Patrassi, N., Basoli, A.: Beta-islet cell tumors of the pancreas: Results of a study on 1067. Surgery75:597, 1974

  11. 11.

    Kümmerle, F., Rückert, K.: Chirurgie des endokrinen Pankreas in der Bundesrepublik. Dtsch. Med. Wochenschr.103:729, 1978

  12. 12.

    Boissel, P., Proye, C.: Les Tumeurs Endocrines du Pancréas, Paris, Masson, 1985

  13. 13.

    Whipple, A.O., Frantz, V.K.: Adenoma of the islet cell with hyperinsulinism. Ann. Surg.101:1299, 1935

  14. 14.

    Daggett, P.R., Kurtz, A.B., Morris, D.V., Goodburn, E.A., Le Quesne, L.P., Nabarro, J.D.N., Raphael, M.J.: Is preoperative localisation of insulinomas necessary. Lancet2:483, 1981

  15. 15.

    Grant, C.S., van Heerden, J.A., Charboneau, J.W., James, F.M., Reading, C.C.: Insulinoma: The value of intraoperative ultrasonography. Arch. Surg.123:843, 1988

  16. 16.

    McMillan, F.L., Scheibe, J.R.: Islet cell tumor of the pancreas. Am. J. Surg.82:759, 1951

  17. 17.

    Klotter, H.J., Rückert, K., Kümmerle, F., Rothmund, M.: The use of intraoperative sonography in endocrine tumors of the pancreas. World J. Surg.11:635, 1987

  18. 18.

    Kennedy, T.: The management of the hypoglycemic patient. World J. Surg.6:718, 1982

  19. 19.

    Rothmund, M., Rückert, K., Beyer, J.: Insulinome und seltene endokrine Pankreastumoren. Chirurg57:541, 1986

Download references

Author information

Correspondence to Matthias Rothmund M.D..

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rothmund, M., Angelini, L., Brunt, L.M. et al. Surgery for benign insulinoma: An international review. World J. Surg. 14, 393–398 (1990). https://doi.org/10.1007/BF01658536

Download citation

Keywords

  • Public Health
  • Success Rate
  • Primary Operation
  • Insulinomas
  • International Review